Great West Life Assurance CO Ultragenyx Pharmaceutical Inc. Transaction History

Great West Life Assurance CO

$63.1 Billion
Q2 2025

A detailed history of Great West Life Assurance CO transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 26,398 shares of RARE stock, worth $913,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,398

Previous 23,461 12.52%

Holding current value

$913,370

Previous $851,000 13.04%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$31.06 - $39.3 $91,223 - $115,424	2,937 Added 12.52%	26,398 $962,000
Q1 2025 May 15, 2025	BUY	$36.21 - $45.78 $11,152 - $14,100	308 Added 1.33%	23,461 $851,000
Q4 2024 Feb 13, 2025	SELL	$42.07 - $57.72 $27,219 - $37,344	-647 Reduced 2.72%	23,153 $972,000
Q3 2024 Nov 13, 2024	SELL	$40.21 - $59.36 $98,434 - $145,313	-2,448 Reduced 9.33%	23,800 $1.32 Million
Q2 2024 Aug 12, 2024	SELL	$37.42 - $51.61 $45,390 - $62,602	-1,213 Reduced 4.42%	26,248 $1.08 Million
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $62,120 - $77,528	-1,444 Reduced 5.0%	27,461 $1.28 Million
Q4 2023 Feb 13, 2024	BUY	$31.73 - $49.19 $44,707 - $69,308	1,409 Added 5.12%	28,905 $1.37 Million
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $225,164 - $300,863	6,448 Added 30.63%	27,496 $980,000
Q2 2023 Aug 10, 2023	BUY	$37.35 - $52.15 $49,264 - $68,785	1,319 Added 6.69%	21,048 $977,000
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $219,387 - $288,899	-5,931 Reduced 23.11%	19,729 $792,000
Q4 2022 Feb 10, 2023	BUY	$33.72 - $46.33 $535,237 - $735,396	15,873 Added 162.18%	25,660 $1.2 Million
Q3 2022 Nov 01, 2022	BUY	$39.96 - $66.14 $391,088 - $647,312	9,787 New	9,787 $404,000
Q2 2022 Aug 09, 2022	BUY	$45.8 - $85.4 $3,160 - $5,892	69 Added 1.98%	3,553 $212,000
Q1 2022 May 12, 2022	SELL	$62.2 - $84.4 $14,057 - $19,074	-226 Reduced 6.09%	3,484 $268,000
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $5,085 - $6,062	69 Added 1.9%	3,710 $311,000
Q2 2021 Aug 11, 2021	SELL	$92.19 - $115.71 $30,238 - $37,952	-328 Reduced 8.26%	3,641 $347,000
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $22,449 - $35,223	210 Added 5.59%	3,969 $448,000
Q3 2020 Nov 17, 2020	SELL	$72.98 - $90.0 $654,995 - $807,750	-8,975 Reduced 70.48%	3,759 $308,000
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $654,995 - $807,750	8,975 Added 238.76%	12,734 $1.05 Million
Q4 2019 Feb 11, 2020	BUY	$36.08 - $45.83 $135,624 - $172,274	3,759 New	3,759 $160,000
Q3 2019 Oct 25, 2019	SELL	$42.5 - $63.11 $299,030 - $444,041	-7,036 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$54.93 - $74.36 $25,267 - $34,205	460 Added 7.0%	7,036 $0
Q1 2019 May 08, 2019	BUY	$39.87 - $69.36 $49,119 - $85,451	1,232 Added 23.05%	6,576 $454,000
Q2 2018 Aug 10, 2018	SELL	$48.54 - $85.31 $42,472 - $74,646	-875 Reduced 14.07%	5,344 $411,000
Q4 2017 Feb 09, 2018	BUY	$43.54 - $57.32 $90,563 - $119,225	2,080 Added 50.25%	6,219 $288,000
Q3 2017 Nov 09, 2017	BUY	$49.79 - $66.32 $206,080 - $274,498	4,139	4,139 $223,000

Others Institutions Holding RARE

# of Institutions

362

Shares Held

88.2M

Call Options Held

3.64M

Put Options Held

2.24M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.42B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Ultragenyx Pharmaceutical Inc. Transaction History